ZENTMAN SAMUEL M 4
4 · Klotho Neurosciences, Inc. · Filed Aug 8, 2025
Insider Transaction Report
Form 4
ZENTMAN SAMUEL M
Director
Transactions
- Award
Common Stock
2025-08-05+153,494→ 736,440 total - Award
Non-Qualified Stock Option
2025-08-07$0.41/sh+10,000$4,100→ 40,000 totalExercise: $0.41Exp: 2035-01-16→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The Reporting Person received the shares as contingent merger consideration.
- [F2]The Reporting Person is the beneficial owner of the shares which are owned by The Samuel Zentman 2012 Irrevocable Trust.
- [F3]Options are fully vested and can be exercised at any time.